小美基因编辑事件 / Xiaomei Gene-Editing Case

Overview

The Xiaomei gene-editing case is the episode’s account of a six-year-old girl with Snyder-Robinson syndrome-related developmental disability and autism-like behavior who died after receiving an immature gene-editing intervention in Shanghai.

Current Profile

The case functions in the wiki as a source-scoped medical-ethics and disability-care event. The episode says Xiaomei’s condition was not immediately fatal, that she could speak full sentences, and that animal experiments had already shown serious organ-damage signals before the human intervention. Her death is used to ask why a child whose life still had possibility became the subject of a high-risk treatment aimed at repairing her difference.

The strongest current synthesis is that the event is not reducible to one party’s bad decision. The source assigns responsibility across parental desperation, research ambition, information disclosure, ethics oversight, high-cost cure markets, and Ableist Cure Pressure / 健全中心主义治愈压力 that makes disabled childhood appear to have no future.

Key Characteristics

• Centers a child whose developmental disability was treated as an error to be corrected despite nonfatal status and remaining development potential.
• Shows how gene-editing promise can become dangerous when risk, evidence, informed consent, and necessity are weak.
• Links parental fear to a wider achievement culture that treats school success, employment, and normality as prerequisites for a valuable life.
• Exposes the gap between professional judgments about disability quality of life and disabled people’s own possible assessment of their lives.
• Becomes a warning case for Autism Cure-Scam Risk and Gene-Editing Treatment Ethics / 基因编辑治疗伦理 rather than a general claim about all gene-editing research.

Evidence

• Case facts in the episode - 从基因编辑女童之死说起：自闭症不是需要被修复的错误 describes Xiaomei as a six-year-old with Snyder-Robinson syndrome, developmental delay, intellectual disability, and autism-like behavior who died after gene-editing treatment.
• Risk and necessity - 从基因编辑女童之死说起：自闭症不是需要被修复的错误 says monkey experiments had shown kidney and liver injury, while Xiaomei’s situation was not presented as terminal.
• Disclosure and publication concerns - 从基因编辑女童之死说起：自闭症不是需要被修复的错误 says the public learned of the case through later reporting around a Nature paper that emphasized successful animal data while the child’s death and human-experiment data were not presented in the same way.
• Social meaning - 从基因编辑女童之死说起：自闭症不是需要被修复的错误 has Xu Yue interpret the event through ableism, parental pressure, and social devaluation of disabled futures.

Qualifications

The wiki records the episode’s account and interpretation. It does not independently adjudicate the full medical record, legal responsibility, research protocol, consent documents, ethics-review process, or the named research team’s response.

What Changed

• Created the case page as the medical-ethics anchor for this autism and disability-support ingest.

Relationships

• 许悦 / Xu Yue - guest who interprets the case through autism, disability, and care ethics.
• 仇子龙 / Qiu Zilong - researcher named by the source in connection with the gene-editing work and publication concerns.
• Gene-Editing Treatment Ethics / 基因编辑治疗伦理 - ethical frame sharpened by the case.
• Ableist Cure Pressure / 健全中心主义治愈压力 - social pressure pattern the episode says made the risky choice intelligible.
• Autism As Human Difference - alternative frame against treating autistic traits as errors to erase.
• Autism Cure-Scam Risk - adjacent cure-market and miracle-treatment risk.